Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey

Perry Elliott, Robert Baker, Ferdinando Pasquale, Giovanni Quarta, Hatim Ebrahim, Atul B Mehta, Derralynn A Hughes, ACES study group

Research output: Contribution to journalArticlepeer-review

154 Citations (Scopus)


The prevalence of Anderson-Fabry disease (AFD) in patients presenting with unexplained left ventricular hypertrophy (LVH) is controversial. The aim of this study was to determine the prevalence of AFD in a large, consecutive cohort of patients with hypertrophic cardiomyopathy (HCM) using rapid mutation screening.
Original languageEnglish
Pages (from-to)1957-60
Number of pages4
Issue number23
Publication statusPublished - Dec 2011


  • Aged
  • Cardiomyopathy, Hypertrophic
  • Cross-Sectional Studies
  • Europe
  • Fabry Disease
  • Female
  • Genetic Testing
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Prevalence
  • alpha-Galactosidase

Cite this